Home / Inspections / 1217513

FDA Inspection 1217513 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on September 7, 2023 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Rye, NY (United States)

Facility

Other inspections at this facility

  • 1283668 (VAI Wed Sep 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1209368 (VAI Thu Jul 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1168524 (NAI Thu Apr 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118178 (VAI Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064704 (NAI Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources